Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.

Suh, Young Sun

Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy. [electronic resource] - Journal of Korean medical science Jan 2014 - 38-42 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1598-6357

10.3346/jkms.2014.29.1.38 doi


Adalimumab
Adult
Aged
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized--adverse effects
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--drug therapy
Enzyme Inhibitors--adverse effects
Etanercept
Female
Humans
Hydroxychloroquine--adverse effects
Immunoglobulin G--adverse effects
Immunosuppressive Agents--adverse effects
Infliximab
Interferon-gamma Release Tests
Male
Methotrexate--adverse effects
Middle Aged
Mycobacterium tuberculosis--isolation & purification
Receptors, Tumor Necrosis Factor--therapeutic use
Retrospective Studies
Spondylitis, Ankylosing--drug therapy
Tuberculin Test
Tuberculosis--chemically induced
Tumor Necrosis Factor-alpha--antagonists & inhibitors